Pathkey.AI

Pathkey.AI is an ASX-listed technology group spanning AI decision software and AI-native semiconductor design. Formerly Opyl, it operates the TrialKey clinical-development platform and acquired Singapore-based Chipforge in June 2026.

Facts

Segment: AI Compute
Country: Australia
Website: https://pathkey.ai/

Market context

Comparable profiles and adjacent companies connected by shared workflow, capability, or stack position.

ADLINK Technology - comparable profile - peer: Industrial Edge Computing Supplier
Chipforge - comparable profile - peer: Industrial Edge Computing Supplier
Pleora Technologies - comparable profile - peer: Industrial Edge Computing Supplier

View market context

Timeline

2026-06-23 - Acquisition - PathKey completes acquisition of 100% of Chipforge - PathKey completed the acquisition of 100% of Chipforge’s issued capital on 23 June 2026. Consideration comprised 560 million fully paid PathKey ordinary shares and 150 million performance rights subject to stated vesting milestones. Chipforge adds agentic-AI… - source: marketindex.com.au

View timeline